Advocacy

ASRA Advocates for Additional Public Health Emergency Funding
Nov 9, 2020
Physicians Report Income Down, PPE Spending Up
Nov 2, 2020
Applications Being Accepted for Additional $20 B in Provider Relief Funds
Oct 5, 2020
Comments on Medicare Program, CY 2021 Address Multiple Concerns
Oct 5, 2020
ASRA Provides Feedback on AHRQ Reports Regarding Acute Pain and Episodic Migraine
Sep 28, 2020
ASRA Joins Plea for Economic Changes in Response to COVID-19
Jul 1, 2020
ASRA Provides Comments to CDC Regarding Opioids and Substance Use Disorder
May 22, 2020
CMS Increasing Telephone E/M Payments, Waives Video Requirement for Certain Services
May 1, 2020
Multisociety Pain Workgroup Responds to Oregon Proposal to Allow APRNs to Supervise Radiologic Technologists
Nov 21, 2019
Comments Submitted Regarding Agency for Healthcare Research and Quality Draft Reports
Nov 19, 2019
ASRA Responds to CMS Revisions to Payment Policies and Other Medicare-Related Requirements
Sep 24, 2019
ASRA MIPS Fact Sheets Revised for 2019
Dec 20, 2018
ASRA Appointed to AMA Specialty Council; Advocates Against Prescription Restrictions
Nov 30, 2018
Comments on 2019 Medicare Physician Fee Schedule Proposed Rule
Sep 10, 2018
ASRA Signs on to Letter to CMS Regarding 2019 Medicare Physician Fee Schedule
Aug 28, 2018
CMS Responds to Complaints of Excessive Administrative Burdens in MIPS ACI
Mar 12, 2018
ASRA Comments on Opioid Product and Policy Issues
Dec 6, 2017
Multisociety Pain Workgroup Issues Statement Repudiating Conclusions of MINT Trials
Nov 22, 2017
ASRA Comments on CMS’s 2018 Proposed Rule
Aug 21, 2017
ASRA Applauds Federal Pain Research Strategy
Jun 5, 2017